You are here:  > Home  > Clinical Resources > Guidelines
Guidelines

Information on guidelines

Included in this page are BSPED guidelines (commissioned and developed by BSPED) and BSPED endorsed guidelines (produced by other national bodies). Each patient should be considered as an individual in the context of their condition and other medication and therefore the readers' discretion is required in the application of their use of these guidelines. Every effort has been made to ensure the factual accuracy of the contents but no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines.

If you have a query or comment, or would like to raise a concern regarding a BSPED guideline, or any guideline on this page, please contact the BSPED Office who will ensure your message is passed to the BSPED Clinical Guidelines Officer and Clinical Committee.

BSPED Guidelines (guidelines produced for the BSPED)

The guidelines included on this page have been commissioned and developed by BSPED and reflect the Society's views on best practice for the majority of patients with that condition.

BSPED Endorsed Guidelines

These guidelines are produced by accredited national bodies (e.g. NICE, RCPCH, ACDC, SIGN), of which BSPED are stakeholders. BSPED may have been involved in the development of these guidelines but are not the original authors of these guidelines. Please review the BSPED Clinical Guideline Endorsement document for the process. Authors of guidelines are required to sign the BSPED Declaration of Interest form (definitions of conflicting interests are listed on the form).

Category Guideline Type Source Date of document Review date
Adrenal Insufficiency

Adrenal Insufficiency Consensus Guidelines

BSPED BSPED Nov 2022 Nov 2025
Bone

Recommendation of Endocrine & Bone Monitoring in Duchenne Muscular Dystrophy (DMD) in the UK NorhtStar Network

Endorsed DMD Care UK Aug 2020 Aug 2023
Bone

Adrenal Insufficiency in DMD / Puberty and Testosterone Treatment in DMD - Patient Information Leaflets

Endorsed DMD Care UK Aug 2020 Aug 2023
DSD

UK Guidance on the Initial Evaluation of an Infant or an Adolescent with a Suspected Disorder of Sex Development

Endorsed Society for Endocrinology April 2021 April 2024
Growth

BSPED UK Consensus National Guidelines for Sex Hormone Priming for Growth Hormone (GH) Stimulation Testing

BSPED BSPED Apr 2021 April 2024
Growth

Shared care guidelines: Paediatric use of Recombinant Human Growth Hormone (r-hGH)

BSPED BSPED Dec 2023 Jan 2027
Growth

Recommendations for rh IGF-1 in Children with SPIGFD

BSPED BSPED May 2024 May 2027
Growth

Recommendations for IGF-1 Therapy in Children with Severe Insulin Resistance Syndromes

BSPED BSPED May 2024 May 2027
Growth Growth Monitoring for Children with Chronic Kidney Disease Endorsed BSPED/BAPN/PRING March 2024 March 2027
Puberty / Gonads Hormone Supplementation for Pubertal Induction in Girls BSPED BSPED June 2022 June 2025
Puberty / Gonads Testosterone Replacement Guidelines  BSPED BSPED April 2019 April 2023
Puberty / Gonads Shared care guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists BSPED BSPED Apr 2021 Apr 2025
Puberty / Gonads GnRH Analogue Stimulation Testing to Investigate Precocious Puberty BSPED BSPED Jul 2021 July 2025
Oncology CCLG: Rare Endocrine Tumour guidelines: Craniopharyngioma Endorsed CCLG 2021 2026
Oncology CCLG: Rare Endocrine Tumour guidelines: Idiopathic thickened pituitary stalk (iTPS) and/or idiopathic central diabetes insipidus (CDI) Endorsed CCLG 2021 2026
Turner Syndrome Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome Endorsed ESPE/International Consensus 2017 2021

Local/ Other Endocrine Guidelines and Useful Resources

These guidelines are local/other endocrine guidelines which have been made available to BSPED members. The BSPED have not been involved in the development of these guidelines and take no responsibility for the content. Please note local guidelines may vary between Trusts.

If a local trust wishes to publish their guidelines on the BSPED website, please email the BSPED Office (bsped@endocrinology.org) and we will put you in touch with our Clinical Guideline Officer, Dr Jarod Wong. 

Category Guideline Type Source Date of document
Adrenal

The Investigation of suspected Paediatric Cushing’s Syndrome

Supported Barts and the London School of Medicine April 2021
Growth

Recombinant IGF-1 Therapy in Children with Severe Primary IGF-1 Deficiency   

Supported Barts and the London School of Medicine April 2021
Puberty/Gonads

Protocol for Induction of Puberty with Gonadotropins in Adolescent Males with GnRH or Gonadotropin Deficiency

Supported QMUL/Barts/UCLH/Alder Hey April 2022
Thyroid

Paediatric Graves Disease Guildeline 2022

Supported British Thyroid Association Guideline management of Paediatric Graves disease 2022
Hyperinsulinism

Management of Congenital Hyperinsulinism 2023

Supported UK national consensus 2023

 

 

Guideline Type Source Date of document /last updated Review date

BSPED Guideline for the Management of Children and Young People under the age of 18 years with Diabetic Ketoacidosis - 2021

BSPED  BSPED  Nov 2021  Nov 2024

DKA Calculator

BSPED BSPED Nov 2021 Nov 2024

DKA Integrated Care Pathway - 2021

BSPED BSPED Nov 2021 Nov 2024

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

Endorsed NICE Dec 2020 May 2023

 

ACDC Endorsed Diabetes Guidelines

Please refer to the ACDC website for Endorsed Guidelines for the most up to date diabetes guidelines listed below.

Guideline Type Source
Executive summary - A Practical Approach to the Management of Type 2 Diabetes in children and young people under 18yrs Endorsed ACDC/BSPED
Care of the Well Child-Newly Diagnosed with Type 1 Diabetes Endorsed ACDC/BSPED
Sick day guideline executive summary v4 Endorsed ACDC/BSPED
Sick day guideline Main V4 Endorsed ACDC/BSPED
Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes Endorsed ACDC/BSPED
A Practical Approach to the Self Management of Diabetes As An Inpatient for Children and Young People Under 18 years Endorsed ACDC/BSPED
A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years Endorsed ACDC/BSPED
A Practical Approach to the Management of Steroid, Chemotherapy or Transplant Induced Hyperglycaemia or Diabetes in Children and Young People Under 18 years in the Acute or Inpatient Setting Endorsed ACDC/BSPED
Dexcom G4 CGM Training Leaflet for Healthcare Professionals and Patients Endorsed ACDC/BSPED
Dexcom G5 CGM Training Leaflet for Healthcare Professionals and Patients Endorsed  ACDC/BSPED
Dexcom G6 CGM Training Leaflet for Healthcare Professionals and Patients Endorsed ACDC/BSPED
Medtronic 640G Training Leaflet for Healthcare Professionals and Patients Endorsed ACDC/BSPED
Libre FGS Training Leaflet for Healthcare Professionals and Patients Endorsed ACDC/BSPED
Care of children under 18 years with Diabetes Mellitus undergoing Surgery - currently being updated Endorsed ACDC/BSPED
Executive Summary: A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years Endorsed ACDC/BSPED
Practical Management of Hyperglycaemic Hyperosmolar State (HHS) in children Endorsed ACDC/BSPED
Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Endorsed ACDC/BSPED
Executive Summary- Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Endorsed ACDC/BSPED
Patient Advice for Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Endorsed ACDC/BSPED

*BSPED DKA Guidelines: The Clinical Committee of BSPED are aware that NICE has published its revised guidance on the management of Type 1 and Type 2 Diabetes in Children and Young People(CG 18) We are also aware that this revised NICE guidance differs from the current interim BSPED guidance on the cloud the fluid management of DKA. The Clinical Committee plan to review this situation very quickly but do not feel that the current BSPED DKA guidance need to be removed from the website while this review and revision takes place.

Chaperone documentation for clinical notes (provided by Birmingham Children's Hospital):

Word version, Excel version, PowerPoint version